Emergent Biosolutions

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$189,300
$293,800
$254,700
$300,400
Gross Profit
71,300
164,200
-54,500
139,400
EBITDA
13,200
177,100
-216,800
65,200
EBIT
-12,800
150,700
-246,200
36,400
Net Income
-31,300
114,800
-283,100
9,000
Net Change In Cash
189,300
293,800
254,700
300,400
Free Cash Flow
-81,600
147,900
42,900
-73,400
Cash
99,500
149,900
71,000
79,000
Basic Shares
53,000
55,600
52,600
52,200

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$1,013,600
$1,049,300
$1,120,900
$1,792,700
Gross Profit
1,013,599
343,900
427,200
1,035,200
EBITDA
36,900
-505,299
-34,400
458,200
EBIT
-71,900
-630,399
-166,000
331,900
Net Income
-190,600
-760,500
-223,800
219,500
Net Change In Cash
1,013,600
1,049,300
1,120,900
1,792,700
Cost of Revenue
65,800
-44,900
Free Cash Flow
35,800
-257,900
-149,900
96,100
Cash
99,500
111,700
642,600
576,100
Basic Shares
53,000
51,200
50,100
54,100

Earnings Calls

Quarter EPS
2024-12-31
-$0.57
2024-09-30
$1.37
2024-06-30
-$2.32
2024-03-31
$0.59